Popular topics
Breaking news and analysis from technology, capital, and policy — the moves that matter for the people building, funding, and regulating the technology economy.
13,389 articles · News
Amsterdam-based Fairphone, the ethical smartphone maker, on Tuesday, announced the appointment of Raymond van Eck as Fairphone’s new CEO.
Leapsprong Amsterdam has unveiled its inaugural cohort of eight innovative startups chosen from a competitive pool of 58 applicants.
Tampere-based ColloidTek (Collo), a Finnish tech company specialising in IoT analysers for optimising industrial liquid processes, has secured €5M in growth funding to support its global expansion.
Ghent-based Accurat.ai, a data-driven software firm that gathers and analyses GDPR data for merchants, has secured €1M in funding to scale its location-based market research operations across Europe.
Riccardo Osti has decided to step down as the CEO of Wonderflow after over ten years.
Gothenburg-based Kognic, an annotation platform helping global enterprises produce and verify sensor-fusion data for high-performing and safe AI, has secured SEK 100M (€8.8M) in funding.
London-based Balderton Capital, a technology venture capital firm, announced on Monday that it has secured $615M (approximately €563M) in…
London-based Gaussion, a magneto-electrochemistry company, announced on Monday that it has secured $12M (approximately €11M) in a Series A funding round led by Autotech Ventures and supported by existing investors BGF and UCL Technology Fund.
In today's fast-paced world, keeping up with the latest news can be a tough task.
Copenhagen-based 2021.AI, a company that claims to be a leader in Responsible AI, has secured DKK 28M (€3.6M) in a bridge funding round, with participation from DNV Ventures and existing investors.
Helsinki, Finland-based Quantlytica, a fintech company, announced on Thursday, August 8, that it has closed €1M in a private raise in grants and investments.
Utah-based Recursion, a clinical-stage biotech company specialising in drug discovery, has entered into a definitive agreement to merge with Oxford-based Exscientia, a clinical-stage drug design and development company, focused on accelerating drug design and development.
